S3 File -

Of the 202 trials, (a) the 9 that ran in India; (b) For the 9 trials in India, a listing of the publications related to each. (c) Of the remaining 193 trials, the 47 (25%) chosen at random to determine whether they might have recruited Indian-origin participants who were based elsewhere. a. For the 9 trials run in India, the following data is provided: NCT ID, All country locations, Drug, Trade Name, Sponsor, Collaborator, Study start date, Study Title, Medical Condition Reported, Participation, Description of participants, and URL. b. For the 9 trials run in India, a list of the publications related to each. c. Of the remaining 193 trials, the 47 (25%) chosen at random to determine whether they might have recruited Indian patients who were based elsewhere. The following data is provided: Trial ID, Number of Asians, Total participants analyzed by race, URL, and Sites in Asia.
(XLS)